ArticleFrontiers in pharmacology2026
Aspirin use and risk of depression: a cross-sectional study.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The association between aspirin use and depression risk remains controversial. Methods: Based on the National Health and Nutrition Examination Survey (NHANES) database from the 2011 to 2018, a cross-sectional study was designed. Depression was estimated using Patient Health Questionnaire-9 (PHQ-9). Multivariable logistic regression models were used to assess the association between aspirin use and depression, adjusting for sociodemographic, lifestyle, and clinical covariates. To explore potential heterogeneity, we stratified the analysis by depression severity and aspirin dose categories. Results: A total of 4,887 participants with a mean age of 65.5 years were included. Of the participants, 1,421 (29%) were identified to be with depression. Aspirin use was inversely associated with the depression ( Conclusion: Aspirin use was inversely associated with depression, particularly mild depression, and the association differed by depression severity and aspirin dose. The clinical benefits and risks of aspirin should be carefully considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.